MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2023 Evaluate
Revenue reduced marginally to stand at Rs. 6719.00 millions during the quarter ended December 2022. The figure stood at Rs. 6879.00 millions during the year-ago period.An average growth of 44.80% was recorded for the quarter ended December 2022 to Rs. 1309.00  millions from Rs. 904.00 millions.Operating profit surged to 1869.00 millions from the corresponding previous quarter of 1435.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202212 202112 % Var
Sales 6719.00 6879.00 -2.33 27701.00 29566.00 -6.31 27701.00 29566.00 -6.31
Other Income 200.00 163.00 22.70 715.00 744.00 -3.90 715.00 744.00 -3.90
PBIDT 1869.00 1435.00 30.24 7759.00 8369.00 -7.29 7759.00 8369.00 -7.29
Interest 4.00 4.00 0.00 17.00 18.00 -5.56 17.00 18.00 -5.56
PBDT 2004.00 1431.00 40.04 9062.00 13243.00 -31.57 9062.00 13243.00 -31.57
Depreciation 100.00 109.00 -8.26 419.00 667.00 -37.18 419.00 667.00 -37.18
PBT 1904.00 1322.00 44.02 8643.00 12576.00 -31.27 8643.00 12576.00 -31.27
TAX 595.00 418.00 42.34 2437.00 3132.00 -22.19 2437.00 3132.00 -22.19
Deferred Tax -35.00 -12.00 191.67 -15.00 -228.00 -93.42 -15.00 -228.00 -93.42
PAT 1309.00 904.00 44.80 6206.00 9444.00 -34.29 6206.00 9444.00 -34.29
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 27.82 20.86 33.35 28.01 28.31 -1.05 28.01 28.31 -1.05
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..